CD4 and neoplasm: Moreover, neoantigen specific CD4+ T cells were able to produce Th1 cytokines, kill irradiated tumor cells and promote epitope spreading, which highlight the critical implication of RT as a combinatorial partner to neoantigen vaccination to improve vaccine efficacy [234].